Intra-cluster and inter-period correlation coefficients for cross-sectional cluster randomised controlled trials for type-2 diabetes in UK primary care

Trials

Volumn 17, Issue 1, 2016, Pages

  Martin, James ^a   Girling, Alan ^a   Nirantharakumar, Krishnarajah ^a   Ryan, Ronan ^a   Marshall, Tom ^a   Hemming, Karla ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cluster randomised trial; Inter period correlation coefficient; Intra cluster correlation coefficient; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLUSTER ANALYSIS; CLUSTER RANDOMIZED CONTROLLED TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTICE; HUMAN; INTERPERIOD CORRELATION COEFFICIENT; INTRACLUSTER CORRELATION COEFFICIENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; UNITED KINGDOM; WITHIN PERIOD CORRELATION COEFFICIENT; BLOOD; METABOLISM; MIDDLE AGED; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME;

AGED; BIOMARKERS; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SAMPLE SIZE; TIME FACTORS; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84981725599     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1532-9     Document Type: Article

References (63)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31-40. doi: 10.1016/s0140-6736(11)60679-x.
2. Donner A, Kong AP. Design and analysis of cluster randomization trials in health research. London: Arnold Publishers Limited; 2000.
3. Edwards SJ, Braunholtz DA, Lilford RJ, Stevens AJ. Ethical issues in the design and conduct of cluster randomised controlled trials. BMJ. 1999;318(7195):1407-9.
4. Donner A. Some aspects of the design and analysis of cluster randomization trials. J R Stat Soc: Ser C: Appl Stat. 1998;47(1):95-113.
5. Campbell MJ, Walters SJ. How to design, analyse and report cluster randomised trials in medicine and health related research. West Sussex: John Wiley & Sons Ltd, Wiley; 2014.
6. Puffer S, Torgerson DJ, Watson J. Cluster randomized controlled trials. J Eval Clin Pract. 2005;11(5):479-83.
7. Eldridge S, Kerry S. A practical guide to cluster randomised trials in health services research. John Wiley & Sons Ltd, Wiley; 2012.
8. Lancaster GA, Campbell MJ, Eldridge S, Farrin A, Marchant M, Muller S, et al. Trials in primary care: statistical issues in the design, conduct and evaluation of complex interventions. Stat Methods Med Res. 2010;19(4):349-77. doi: 10.1177/0962280209359883.
9. Campbell MJ. Cluster randomized trials in general (family) practice research. Stat Methods Med Res. 2000;9(2):81-94.
10. Donner A, Klar N. Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996;49(4):435-9.
11. Kerry SM, Bland JM. Trials which randomize practices II: sample size. Fam Pract. 1998;15(1):84-7.
12. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999;28(2):319-26.
13. Hayes R, Moulton L. Cluster randomised trials. Boca Raton: Chapman & Hall/CRC; 2009.
14. Khunti K, Gray LJ, Skinner T, Carey ME, Realf K, Dallosso H, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ. 2012;344:e2333.
15. Foster GD, Linder B, Baranowski T, Cooper DM, Goldberg L, Harrell JS, et al. A school-based intervention for diabetes risk reduction. N Engl J Med. 2010;363(5):443-53. doi: 10.1056/NEJMoa1001933.
16. Shahbazian H, Latifi SM, Jalali MT, Shahbazian H, Amani R, Nikhoo A, et al. Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diabetes Metab Disord. 2013;12(1):11. doi: 10.1186/2251-6581-12-11.
17. Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012;125(23):2863-72. doi: 10.1161/CIRCULATIONAHA.111.089169.
18. Echouffo-Tcheugui J, Simmons R, Williams K, Barling R, Prevost AT, Kinmonth A, et al. The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health. 2009;9(1):136.
19. Hansen LJ, Siersma V, Beck-Nielsen H, de Fine Olivarius N. Structured personal care of type 2 diabetes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP). Diabetologia. 2013;56(6):1243-53. doi: 10.1007/s00125-013-2893-1.
20. Hemming K, Girling AJ, Sitch AJ, Marsh J, Lilford RJ. Sample size calculations for cluster randomised controlled trials with a fixed number of clusters. BMC Med Res Methodol. 2011;11:102. doi: 10.1186/1471-2288-11-102.
21. Eldridge SM, Ukoumunne OC, Carlin JB. The intra-cluster correlation coefficient in cluster randomized trials: a review of definitions. Int Stat Rev. 2009;77(3):378-94.
22. Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M. Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract. 2000;17(2):192-6.
23. Bell ML, McKenzie JE. Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures. Psycho-Oncology. 2013;22(8):1738-47. doi: 10.1002/pon.3205.
24. Parienti JJ, Kuss O. Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies. Contemp Clin Trials. 2007;28(3):316-23. doi: 10.1016/j.cct.2006.10.004.
25. Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391. doi: 10.1136/bmj.h391.
26. Martin J, Taljaard M, Girling A, Hemming K. Systematic review finds major deficiencies in sample size methodology and reporting for stepped-wedge cluster randomised trials. BMJ Open. 2016;6(2):e010166. doi: 10.1136/bmjopen-2015-010166.
27. Hooper R, Bourke L. The dog-leg: an alternative to a cross-over design for pragmatic clinical trials in relatively stable populations. Int J Epidemiol. 2014;43(3):930-6. http://dx.doi.org/10.1093/ije/dyt281.
28. Hooper R, Bourke L. Cluster randomised trials with repeated cross sections: alternatives to parallel group designs. BMJ. 2015;350:h2925. doi: 10.1136/bmj.h2925.
29. Taljaard M, Teerenstra S, Ivers NM, Fergusson DA. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs. Clin Trials (London, England). 2016. doi: 10.1177/1740774516634316.
30. Girling AJ, Hemming K. Statistical efficiency and optimal design for stepped cluster studies under linear mixed effects models. Stat Med. 2016;35(13):2149-66. doi: 10.1002/sim.6850.
31. Ukoumunne OC, Thompson SG. Analysis of cluster randomized trials with repeated cross-sectional binary measurements. Stat Med. 2001;20(3):417-33.
32. Turner RM, White IR, Croudace T. Analysis of cluster randomized cross-over trial data: a comparison of methods. Stat Med. 2007;26(2):274-89. doi: 10.1002/sim.2537.
33. Webb DR, Khunti K, Gray LJ, Srinivasan BT, Farooqi A, Wareham N, et al. Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial. Diabet Med. 2012;29(4):531-40. doi: 10.1111/j.1464-5491.2011.03441.x.
34. Taljaard M, Donner A, Villar J, Wojdyla D, Velazco A, Bataglia V, et al. Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation research. Paediatr Perinat Epidemiol. 2008;22(2):117-25. doi: 10.1111/j.1365-3016.2007.00901.x.
35. Gulliford MC, Adams G, Ukoumunne OC, Latinovic R, Chinn S, Campbell MJ. Intraclass correlation coefficient and outcome prevalence are associated in clustered binary data. J Clin Epidemiol. 2005;58(3):246-51. doi: 10.1016/j.jclinepi.2004.08.012.
36. Research CM. Our data. 2012. http://csdmruk.cegedim.com/our-data/our-data.shtml. Accessed 20 Feb 2015.
37. Teerenstra S, Eldridge S, Graff M, de Hoop E, Borm GF. A simple sample size formula for analysis of covariance in cluster randomized trials. Stat Med. 2012;31(20):2169-78. doi: 10.1002/sim.5352.
38. Bebb C, Kendrick D, Coupland C, Madeley R, Stewart J, Brown K, et al. A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetes. Br J Gen Pract. 2007;57(535):136-43.
39. Smith SM, Paul G, Kelly A, Whitford DL, O'Shea E, O'Dowd T. Peer support for patients with type 2 diabetes: cluster randomised controlled trial. BMJ. 2011;342:d715. doi: 10.1136/bmj.d715.
40. (NICE) NIfHaCE. Type 2 diabetes: the management of type 2 diabetes. NICE guidelines [CG87]; John Wiley & Sons Ltd; 2009.
41. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet. 375(9713);481-9. http://dx.doi.org/10.1016/S0140-6736(09)61969-3.
42. Kirby M. Achieving effective lipid management in diabetes. Br J Prim Care Nurs. 2009;6(2):S10-S11.
43. Association AD. Standards of medical care in diabetes-2007. Diabetes Care. 2007;30 Suppl 1:S4-41. doi: 10.2337/dc07-S004.
44. (NICE) NIfHaCE. Quality and outcomes framework indicators. 2004. https://www.nice.org.uk/Standards-and-Indicators/QOFIndicators. Accessed 11 June 2015.
45. Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18(1):76-83. doi: 10.1002/pds.1688.
46. O'Hare JP, Raymond NT, Mughal S, Dodd L, Hanif W, Ahmad Y, et al. Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS). Diabet Med. 2004;21(12):1357-65. doi: 10.1111/j.1464-5491.2004.01373.x.
47. Bellary S, O'Hare JP, Raymond NT, Gumber A, Mughal S, Szczepura A, et al. Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet. 2008;371(9626):1769-76. doi: 10.1016/s0140-6736(08)60764-3.
48. Sturt JA, Whitlock S, Fox C, Hearnshaw H, Farmer AJ, Wakelin M, et al. Effects of the Diabetes Manual 1:1 structured education in primary care. Diabet Med. 2008;25(6):722-31. doi: 10.1111/j.1464-5491.2008.02451.x.
49. Mathers N, Ng CJ, Campbell MJ, Colwell B, Brown I, Bradley A. Clinical effectiveness of a patient decision aid to improve decision quality and glycaemic control in people with diabetes making treatment choices: a cluster randomised controlled trial (PANDAs) in general practice. BMJ Open. 2012;2(6). doi: 10.1136/bmjopen-2012-001469.
50. Dallosso HM, Eborall HC, Daly H, Martin-Stacey L, Speight J, Realf K, et al. Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol. BMC Fam Pract. 2012;13:18. doi: 10.1186/1471-2296-13-18.
51. Smith S, Bury G, O'Leary M, Shannon W, Tynan A, Staines A, et al. The North Dublin randomized controlled trial of structured diabetes shared care. Fam Pract. 2004;21(1):39-45.
52. Wu S, Crespi CM, Wong WK. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials. Contemp Clin Trials. 2012;33(5):869-80. doi: 10.1016/j.cct.2012.05.004.
53. Pagel C, Prost A, Lewycka S, Das S, Colbourn T, Mahapatra R, et al. Intracluster correlation coefficients and coefficients of variation for perinatal outcomes from five cluster-randomised controlled trials in low and middle-income countries: results and methodological implications. Trials. 2011;12:151. doi: 10.1186/1745-6215-12-151.
54. Yelland LN, Salter AB, Ryan P, Laurence CO. Adjusted intraclass correlation coefficients for binary data: methods and estimates from a cluster-randomized trial in primary care. Clin Trials (London, England). 2011;8(1):48-58. doi: 10.1177/1740774510392256.
55. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004;57(8):785-94. doi: 10.1016/j.jclinepi.2003.12.013.
56. Roudsari B, Fowler R, Nathens A. Intracluster correlation coefficient in multicenter childhood trauma studies. Inj Prev. 2007;13(5):344-7. doi: 10.1136/ip.2007.015313.
57. Thompson DM, Fernald DH, Mold JW. Intraclass correlation coefficients typical of cluster-randomized studies: estimates from the Robert Wood Johnson Prescription for Health projects. Ann Fam Med. 2012;10(3):235-40. doi: 10.1370/afm.1347.
58. Kul S, Vanhaecht K, Panella M. Intraclass correlation coefficients for cluster randomized trials in care pathways and usual care: hospital treatment for heart failure. BMC Health Serv Res. 2014;14:84. doi: 10.1186/1472-6963-14-84.
59. Moineddin R, Matheson FI, Glazier RH. A simulation study of sample size for multilevel logistic regression models. BMC Med Res Methodol. 2007;7:34. doi: 10.1186/1471-2288-7-34.
60. Turner RM, Omar RZ, Thompson SG. Bayesian methods of analysis for cluster randomized trials with binary outcome data. Stat Med. 2001;20(3):453-72.
61. Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290-7. doi: 10.1136/jech.2004.029454.
62. Giraudeau B, Ravaud P, Donner A. Sample size calculation for cluster randomized cross-over trials. Stat Med. 2008;27(27):5578-85. doi: 10.1002/sim.3383.
63. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182-91. doi: 10.1016/j.cct.2006.05.007.